Impact of antioxidative treatment on nuclear factor kappa-B regulation during myocardial ischemia-reperfusion.

Nuclear factor kappa-B (NFkappaB), a transcription factor, plays a role in numerous pathological states such as myocardial ischemia-reperfusion (I/R), apoptosis, and ischemic preconditioning. As both myocardial ischemia and reperfusion (by reactive oxygen intermediates) can activate NFkappaB, we investigated the impact of the antioxidant N-acetylcysteine (NAC) on NFkappaB-regulation in patients subjected to cardioplegic arrest (CA) on cardiopulmonary bypass (CPB). Seventeen coronary artery surgery patients (66+/-9[S.D.] years) subjected to cardiopulmonary bypass (CPB) and cardioplegic arrest were randomized in a double-blind fashion to receive either NAC (100 mg/kg into CPB prime followed by infusion at 20 mg/kg/h; n=9) or placebo (n=8). Transmural LV biopsies were collected prior to CPB (baseline) and at CPB-end and immuno-cytochemically stained against active NFkappaB and phosphorylated IkappaB alpha (activates NFkappaB). At the end of CPB both NFkappaB and IkappaB alpha were unchanged in endothelial cells of controls compared to baseline (45.6+/-7.6 vs. 49.9+/-7.1 and 36.8+/-6.1 vs. 47.5+/-8.6 counts per viewfield (cpv), P>0.05, respectively). In NAC, NFkappaB and IkappaB alpha in endothelial cells were significantly decreased at CPB-end (19.8+/-1.7 vs. 39.1+/-4.1 cpv, P<0.001, and 22.1+/-1.9 vs. 38.3+/-4.4 cpv, P=0.006). In cardiomyocytes, however, there were no changes observed in either group. Antioxidative treatment with NAC decreases NFkappaB-activity following I/R in endothelial cells. We conclude that NFkappaB-activity post I/R is mediated by free radicals rather than ischemia alone.

[1]  G. Valen.  Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure , 2003, Basic Research in Cardiology.

[2]  A. Kharazmi,et al.  The role of N-acetylcystein administration on the oxidative response of neutrophils during cardiopulmonary bypass , 1995, Perfusion.

[3]  G. Freeman,et al.  Induction of nuclear factor κB and activation protein 1 in postischemic myocardium , 1997, FEBS letters.

[4]  D. Warltier,et al.  The leukocyte cell adhesion cascade and its role in myocardial ischemia-reperfusion injury , 1997, Basic Research in Cardiology.

[5]  Michael Karin,et al.  Is NF‐κB the sensor of oxidative stress? , 1999 .

[6]  W. Bloch,et al.  Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery. , 2004, The Journal of thoracic and cardiovascular surgery.

[7]  G. Bernard,et al.  Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. , 1984, The Journal of clinical investigation.

[8]  G. Hansson,et al.  Nuclear factor kappa-B and the heart. , 2001, Journal of the American College of Cardiology.

[9]  S. Allen,et al.  The antioxidant N-acetylcysteine preserves myocardial function and diminishes oxidative stress after cardioplegic arrest. , 2003, The Journal of thoracic and cardiovascular surgery.

[10]  B. Price,et al.  An essential role of NFκB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia , 1998, FEBS letters.

[11]  T. Ogihara,et al.  In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction , 1997, Nature Medicine.

[12]  R. Kao,et al.  Early activation of transcription factor NF-κB during ischemia in perfused rat heart. , 1999, American journal of physiology. Heart and circulatory physiology.

[13]  G. Valen,et al.  Induction of inflammatory mediators during reperfusion of the human heart. , 2001, The Annals of thoracic surgery.

[14]  R. Flanagan,et al.  Use of N-acetylcysteine in clinical toxicology. , 1991, The American journal of medicine.

[15]  W Zidek,et al.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.